# Saffron Mood Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/saffron-mood-randomized-trial-evidence-review
Category: evidence-review
Summary: Saffron Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed bio
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Saffron Mood Randomized Trial: What the Evidence Says

## Quick Answer

Saffron Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks | narrative review | 3 | 2026-02-28 | 10.3390/ph19030399 |
| Mood food: antidepressant effects of culinary spices | narrative review | 3 | 2026-02-25 | 10.3389/fnut.2026.1790721 |

## What The Sources Report

- Although these products are available without a prescription and are generally thought to be safe, there are pharmacological and toxicological risks associated with their use. [Căuș Maria-Nina (2026); evidence level 3]
- The differences in the regulatory framework allow for broad consumer access to plant-based products; it also creates potential gaps in safety monitoring and risk communication. [Căuș Maria-Nina (2026); evidence level 3]
- In this review, we want to systematically sort out the evidence about the antidepressant effects of five main culinary spices: turmeric, saffron, ginger, chili pepper and black pepper. [Zhong Lu (2026); evidence level 3]
- Now there is more and more evidence that depression is actually a systemic inflammatory problem, people with MDD have a higher comorbidity rate with immune and inflammatory diseases such as rheumatoid arthritis, metabolic syndrome, and inflammatory bowel disease (-). [Zhong Lu (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For saffron mood randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Căuș Maria-Nina (2026). Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks. DOI: 10.3390/ph19030399. PMCID: PMC13028908. PMID: 41901246. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13028908/
- Zhong Lu (2026). Mood food: antidepressant effects of culinary spices. DOI: 10.3389/fnut.2026.1790721. PMCID: PMC12933273. PMID: 41756633. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12933273/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.